Ketamine enhancement of dexmedetomidine attenuation of methamphetamine-induced agitation in rats
-agonist side effects were less intense and of shorter duration. These data provide proof-of-concept support for the potential use of DEX-KET in producing deeper sedation in METH-induced agitation.
Authors
- Michael D. Hambuchen (ORCID: https://orcid.org/0000-0003-1514-3744)
- K. Bailey
- Todd H. Davies
- Jyostna Yalakala
- Surya Karuturi
- Madison B. Skeen
- Chelsey McPhillen
- Madhuri Budamkayala
Institutions
- Marshall Medical Center (US)
- Marshall Health (US)
- Marshall University (US)
Publication Details
- Journal
- Journal of Pharmacy & Pharmaceutical Sciences
- Published
- 2026-04-15
- DOI
- https://doi.org/10.3389/jpps.2026.16294
- Primary Topic
- Veterinary Pharmacology and Anesthesia
- Type
- article
- Field-Weighted Citation Impact
- 0.00